Notably, microbiome transplantation in depression models (63) and probiotic interventions in Parkinson’s disease (64) have been shown to reduce pro-inflammatory cytokines (e.g., IL-1β, TNF-α) and normalize microglial activity. The gene discussed is IL1B; the disease is depressive symptom measurement.